Global Thrombectomy Devices Market Size and Trends Report Segmented by Device Type (Mechanical, Aspiration, Rheolytic), Application (Neurovascular, Cardiovascular, Peripheral), and End User (Hospitals, Ambulatory Surgical Centers), Regional Forecast to 2029

The global thrombectomy devices market is projected to grow at a CAGR of 6-8% from 2024 to 2029. This growth is primarily driven by an increasing prevalence of stroke and cardiovascular diseases, demand for minimally invasive procedures, and technological advancements in thrombectomy devices. Expansion in emerging markets, combined with an aging population prone to vascular diseases, is expected to further propel market growth. 

Report Overview

The thrombectomy devices market focuses on devices used to remove clots from blood vessels to restore normal blood flow, critical in treating stroke and heart attack patients. This market includes diverse thrombectomy techniques such as aspiration, mechanical, and rheolytic, providing options for minimally invasive clot retrieval. Innovations like aspiration catheter systems with improved clot removal efficiency and stent retriever advancements support detailed, effective vascular treatment across hospitals and specialized clinics globally.

To learn more about the research report, download a sample report.

Rising Demand for Thrombectomy in Stroke and Cardiovascular Procedures

The rise in the global burden of stroke and cardiovascular conditions drives the thrombectomy devices market. Real-time, minimally invasive thrombectomy procedures provide better outcomes and recovery times. Cardiovascular diseases accounts for approximately one third of all global deaths, with ischemic stroke as a leading cause. National initiatives such as the "Billion Hearts" program in the U.S. and substantial R&D investments in stroke care underscore the ongoing need for effective treatment tools like thrombectomy. Technological advancements, such as next-generation aspiration catheters and stent retrievers, support more precise clot removal, fueling the market growth.

To learn more about the research report, download a sample report.

Technological Advancements to Drive Thrombectomy Devices Market Growth

Technological advancements are driving the growth of the thrombectomy devices market, as companies introduce innovative devices that improve safety, efficiency, and clinical outcomes. For instance, Penumbra Inc. launched the Lightning Flash system in 2023, integrating intelligent aspiration technology that uses pressure and flow-based algorithms to detect and remove large clots, especially for deep vein thrombosis and pulmonary embolism cases-. Inari Medical followed suit in 2023 with the RevCore catheter, specifically designed for venous in-stent thrombosis, alongside the Triever16 Curve, which enhances precision for both pulmonary embolism and peripheral thrombectomy treatments-. These product launches highlight the industry-s focus on developing versatile and advanced solutions, far and neurological applications.

Competitive Landscape Analysis

In the competitive landscape of the thrombectomy devices market, several prominent players drive innovation and market expansion through strategic investments, partnerships, and technological advancements. Key companies include Medtronic; Boston Scientific; Stryker Corporation; Penumbra Inc.; Edwards Lifesciences; Abbott Laboratories; Terumo Corporation; AngioDynamics, Inc.; Spectranetics Corporation; and Inari Medical; among others. These firms focus on improving device efficacy, expanding product offerings, and forming partnerships to broaden their portfolios and global reach.

Report Scope

Report Scope	Details
Base Year Considered	2023
Historical Data	2022 - 2023
Forecast Period	2024 - 2029
Market Drivers	Rising prevalence of stroke and cardiovascular diseases Growing demand for minimally invasive procedures Technological advancements in thrombectomy devices Increasing healthcare expenditures
Market Restraints	Inconsistent reimbursement in developing countries Limited adoption in low-resource settings
Segment Scope	Device Type, Application, and End User
Regional Scope	North America (US & Canada) Europe (UK, Germany, France, Italy, Spain, Rest of Europe) Asia Pacific (China, India, Japan, Rest of Asia Pacific) Latin America Middle East & Africa
Key Companies Mapped	Medtronic; Boston Scientific; Stryker Corporation; Penumbra Inc.; Edwards Lifesciences; Abbott Laboratories; Terumo Corporation; AngioDynamics, Inc.; Spectranetics Corporation; and Inari Medical; among others
Report Highlights	Market Size & Forecast, Growth Drivers & Restraints, Trends, Competitive Analysis

Market Segmentation

This report by Medi-Tech Insights provides the size of the global thrombectomy devices market at the regional- and country-level from 2022 to 2029. The report further segments the market based on device type, application, and end user.

• Market Size & Forecast (2022-2029), By Device Type, USD Billion
  • Mechanical/Fragmentation Thrombectomy Devices
  • Aspiration Thrombectomy Devices
  • Rheolytic/Hydrodynamic Thrombectomy Devices
  • Ultrasound-assisted Thrombectomy Devices
  • Others
• Market Size & Forecast (2022-2029), By Application, USD Billion
  • Neurovascular Thrombectomy
  • Cardiovascular Thrombectomy
  • Peripheral Thrombectomy
• Market Size & Forecast (2022-2029), By End User, USD Billion
  • Hospitals and Health Systems
  • Ambulatory Surgical Centers (ASCs)
  • Others
• Market Size & Forecast (2022-2029), By Region, USD Billion
  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of Asia Pacific
  • Latin America
  • Middle East & Africa